Complete Guide to Cholesterol Medications

Why Cholesterol Management Matters

Cholesterol is a fatty substance carried in the blood by lipoproteins. LDL ("bad" cholesterol) deposits in artery walls, contributing to plaques that can rupture and cause heart attacks or strokes. HDL ("good" cholesterol) helps remove LDL from arteries. Triglycerides — another blood fat — also raise cardiovascular risk when elevated.

Medications are used when diet and lifestyle changes are not enough to reach targets, or when cardiovascular risk is high enough that aggressive treatment is warranted from the start. The primary goal in most patients is lowering LDL.

Statins: The Backbone of Treatment

Statins are the most widely prescribed cholesterol-lowering class and have the strongest evidence for reducing heart attacks and strokes. Decades of large clinical trials show they lower major cardiovascular events by 25–35% in high-risk patients.

Common examples: atorvastatin (Lipitor), rosuvastatin (Crestor), simvastatin, pravastatin, lovastatin, fluvastatin, pitavastatin.

How Statins Work: Enzyme InhibitionEnzyme Inhibition

The process by which a drug decreases the activity of metabolizing enzymes, leading to slower breakdown and increased blood levels of co-administered drugs. Unlike induction, inhibition can occur rapi

Statins work through enzyme inhibition — they block HMG-CoA reductase, the key enzyme the liver uses to produce cholesterol. When cholesterol synthesis drops, liver cells increase the number of LDL receptors on their surface to pull more LDL out of the bloodstream. The combined effect lowers blood LDL by 30–55% depending on the statin and dose.

This mechanism also reduces inflammation in artery walls, which partly explains why statins reduce cardiovascular events even beyond their LDL-lowering effect.

Statin Intensity Levels

Statins are classified by their LDL-lowering potencyPotency

The amount of drug needed to produce a given effect. A more potent drug achieves the same effect at a lower dose. Potency is different from efficacy — a drug can be highly potent but have limited maxi

High-intensity statins are recommended for people with established heart disease, very high LDL, or high 10-year cardiovascular risk.

Ezetimibe

Ezetimibe works differently from statins — it blocks the absorption of cholesterol in the small intestine by inhibiting a protein (NPC1L1) in the intestinal wall. It lowers LDL by about 18–20% on its own.

Ezetimibe is most commonly used in combination with a statin, adding an extra LDL reduction of 20–25 percentage points on top of the statin effect. It is available as a fixed-dose combination pill with simvastatin (Vytorin) or with atorvastatin.

It is well tolerated and is a preferred add-on when statins alone are not reaching target LDL levels.

PCSK9 Inhibitors

PCSK9 inhibitors are injectable biologics that take a more aggressive approach: they block a protein (PCSK9) that normally degrades LDL receptors on liver cells. By preserving those receptors, more LDL is cleared from the blood. They can lower LDL by 50–60% on top of a statin.

Common examples: evolocumab (Repatha), alirocumab (Praluent) — both injected every 2–4 weeks.

PCSK9 inhibitors are used for people who cannot reach their LDL target despite maximum statin and ezetimibe therapy, or for those who cannot tolerate statins. They have proven cardiovascular benefit but are expensive. Inclisiran is a newer RNA-based option in the same pathway, injected twice yearly.

Fibrates and Omega-3 Fatty Acids

Fibrates (fenofibrate, gemfibrozil) primarily lower triglycerides (by 30–50%) and modestly raise HDL. They are mainly used when triglycerides are very high (above 500 mg/dL), where the immediate concern is pancreatitis risk.

High-dose omega-3 fatty acids (icosapentaenoic acid, EPA — brand name Vascepa) at prescription doses (4 g/day) lower triglycerides and have shown cardiovascular benefit in patients already on statins.

Bile Acid Sequestrants

Bile acid sequestrants (cholestyramine, colesevelam, colestipol) bind bile acids in the gut, preventing their reabsorption. The liver compensates by converting more cholesterol into bile acids, lowering blood cholesterol. They lower LDL by 15–30%.

They are rarely first-line today but are useful when statins are not tolerated or in special situations (e.g., colesevelam is also FDA-approved to lower blood sugar in type 2 diabetes). They can cause bloating and constipation and interfere with absorption of other medications.

Statin Side Effects and Muscle Concerns

Statins are generally well tolerated. The most discussed side effect is muscle pain (myalgia), reported by 5–10% of users in clinical practice. True serious muscle damage (rhabdomyolysis) is rare — occurring in about 1 in 10,000 treated patients.

If you experience muscle pain on a statin: - Report it to your doctor before stopping the medication - A different statin at a lower dose often resolves the problem - CoQ10 supplementation is sometimes tried, though evidence is limited - True statin intolerance (inability to tolerate any statin) is uncommon — most people can find a tolerable regimen

Statins can mildly raise blood sugar, slightly increasing the risk of type 2 diabetes — but the cardiovascular benefits far outweigh this risk for most people.

Key Takeaways

• Statins are the most evidence-backed cholesterol medications, reducing heart attack and stroke risk through enzyme inhibition of cholesterol synthesis.
• Statin intensity determines how much LDL reduction is achieved — high-intensity statins are used for the highest-risk patients.
• Ezetimibe and PCSK9 inhibitors are add-on or alternative options when statins are insufficient or not tolerated.
• Fibrates and omega-3s primarily target very high triglycerides.
• Muscle pain is the most commonly reported statin side effect but rarely signals serious harm — talk to your doctor before stopping.